- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Warsaw Today
By the People, for the People
OrthoPediatrics Beats Q4 Earnings Estimates
Medical device company reports strong revenue growth and improved profitability metrics
Published on Feb. 27, 2026
Got story updates? Submit your updates here. ›
OrthoPediatrics (NASDAQ:KIDS), a medical device company focused on pediatric orthopedic solutions, announced its Q4 2025 earnings results on Thursday. The company reported a loss of $0.26 per share, beating analysts' consensus estimate of a $0.29 loss per share. Revenue for the quarter came in at $61.61 million, up 17% year-over-year and exceeding the expected $61.27 million.
Why it matters
OrthoPediatrics' better-than-expected financial performance highlights the company's ability to drive revenue growth and improve profitability, even in a challenging economic environment. The company's focus on innovation and international expansion are seen as key drivers for future success.
The details
In the earnings release, OrthoPediatrics noted that Q4 revenue grew 17% year-over-year to $61.61 million, while full-year 2025 revenue increased 15%. The company also reported material improvements in adjusted EBITDA and free cash flow, with Q4 free cash flow of $10 million. Management reiterated its 2026 guidance of $262-$266 million in revenue, around $25 million in adjusted EBITDA, and full-year free cash flow breakeven.
- OrthoPediatrics reported its Q4 2025 earnings results on Thursday, February 27, 2026.
The players
OrthoPediatrics
A medical device company dedicated exclusively to providing orthopedic solutions for children.
The takeaway
OrthoPediatrics' strong Q4 performance and optimistic outlook for 2026 suggest the company is well-positioned to continue its growth trajectory, driven by new product launches, international expansion, and operational improvements. The results highlight the company's ability to navigate industry challenges and deliver value for shareholders.
